Litcius/Paper detail

Repurposing FDA approved drugs as possible anti-SARS-CoV-2 medications using ligand-based computational approaches: sum of ranking difference-based model selection

Priyanka De, Vinay Kumar, Supratik Kar, Kunal Roy, Jerzy Leszczyński

2022Structural Chemistry20 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryRanking (information retrieval)Drug repositioningSelection (genetic algorithm)RepurposingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakPharmacologyComputational biologyDrugMachine learningComputer scienceInternal medicineVirologyMedicineEcologyInfectious disease (medical specialty)BiologyDiseaseOutbreakComputational Drug Discovery MethodsCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research
Repurposing FDA approved drugs as possible anti-SARS-CoV-2 medications using ligand-based computational approaches: sum of ranking difference-based model selection | Litcius